e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Cigarette smoke and particulate matter: basic science and clinical aspects
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Low Level Laser therapy (LLL) modulates pulmonary immune response and expression of P2X7 purinergic receptor in experimental model of Chronic Obstructive Pulmonary Disorder (COPD)
C. Alves (Itapecerica da Serra, Brazil)
Source:
International Congress 2017 – Cigarette smoke and particulate matter: basic science and clinical aspects
Session:
Cigarette smoke and particulate matter: basic science and clinical aspects
Session type:
Poster Discussion
Number:
4457
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Alves (Itapecerica da Serra, Brazil). Low Level Laser therapy (LLL) modulates pulmonary immune response and expression of P2X7 purinergic receptor in experimental model of Chronic Obstructive Pulmonary Disorder (COPD). 4457
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Expression and function of IL-20 cytokines and their receptors on the airway epithelium during Chronic Obstructive Pulmonary Disease (COPD)
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
Effect of smoking on the specific cholinergic hypersensitivity of airways in patients with Chronic Obstructive Pulmonary Disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 178s
Year: 2002
Expression of muscarinic receptors by human macrophages
Source: Eur Respir J 2012; 39: 698-704
Year: 2012
Metabolic paralysis in systemic immune cells of Chronic Obstructive Pulmonary Disease (COPD) subjects.
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018
Assessment of lung function in symptomatic and asymptomatic smokers without Chronic Obstructive Pulmonary Disease (COPD) using the Impulse Oscillatory Technique (IOT)
Source: Virtual Congress 2020 – Health effects of inhaled nicotine devices: from smoking to vaping and heated tobacco
Year: 2020
Altered P2 receptor expression profile in sputum cells of patients with COPD
Source: International Congress 2014 – Monitoring COPD with different biomarkers
Year: 2014
Chronic Obstructive Pulmonary Disease (COPD) patients with airway eosinophilic inflammation are characterized by lower functional impairment.
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019
Putative role of Eosinophilic cells in Chronic Obstructive Pulmonary Disease (COPD)
Source: International Congress 2017 – Translational studies of lung disease
Year: 2017
Late Breaking Abstract - Inhaled corticosteroids (ICS), blood eosinophils (EOS), and FEV1 decline in patients with Chronic Obstructive Pulmonary Disease in a large UK primary healthcare setting
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Year: 2018
Systemic inflammatory response to smoking in chronic obstructive pulmonary disease: Evidence of a gender effect
Source: International Congress 2014 – Basic and translational research in asthma and COPD
Year: 2014
Selective endothelin-A receptor blockade attenuates bleomycin-induced pulmonary inflammation and fibrosis in mice
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
M2 macrophages derived from patients with idiopathic pulmonary arterial hypertension are susceptible for apelin-mediated suppression of pro-inflammatory cytokines
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014
Relationship between functional capacity, dynamic and static muscle function assessments in people with Chronic Obstructive Pulmonary Disease (COPD)
Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care
Year: 2018
Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study
Source: Eur Respir J 2010; 35: 540-548
Year: 2010
Effect of roflumilast on cytokines levels in patients with Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021
New IL-1 family IL-38 is highly expressed in alveolar cells of drug-induced lung injury and idiopathic pulmonary fibrosis
Source: International Congress 2016 – ILD pathogenesis
Year: 2016
Preventive and therapeutic treatment with a7 nicotinic receptor agonist reduced lung inflammation and collagen deposition in mice with acute lung injury
Source: International Congress 2014 – Experimental models in acute lung injury
Year: 2014
Role of endothelin B receptor in Th2-induced pulmonary vascular hyperresponsiveness
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013
Associations of gut microbiota and Chronic Obstructive Pulmonary Disease Assessment Test (CAT) score in chemotherapy treated lung cancer patients with COPD
Source: International Congress 2019 – Treatment of lung cancer
Year: 2019
PPAR-alpha agonist (fenofibrate) therapy in exacerbation control of chronic obstructive pulmonary disease of severe stage
Source: International Congress 2014 – New treatments for cough, asthma, COPD and ILDs
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept